MedTrace Logo

Persistent Cervical HPV Infection With Clearance and Vaginal Microbiota

NCT03895866 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2019-08-29

No results posted yet for this study

Summary

Since other genital infections enhance HIV susceptibility by inducing inflammation, the investigators study the relationship between the vaginal microbiota composition and the persistence infection and clearance of HPV infection.

Conditions

  • HPV-Related Squamous Cell Carcinoma

Interventions

OTHER

The participants were assigned to different groups according to the results of HPV detection.

The participants were assigned to different groups according to the results of HPV detection

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-11
Primary Completion
2020-02-11
Completion
2020-02-11

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03895866 on ClinicalTrials.gov